Momenta Pharmaceuticals logo
Momenta Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Oncology Drug Candidate M402
June 04, 2012 09:00 ET | Momenta Pharmaceuticals
CHICAGO, June 4, 2012 (GLOBE NEWSWIRE) -- Preclinical data for M402, a novel oncology drug candidate being developed by Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), showed that M402 in combination...
Momenta Pharmaceuticals logo
Momenta to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference
May 30, 2012 08:30 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 30, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals logo
Momenta to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 11, 2012 08:00 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 11, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals logo
Momenta Pharmaceuticals Reports First Quarter 2012 Financial Results
May 03, 2012 08:00 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., May 3, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals logo
Momenta Pharmaceuticals Announces Date of First Quarter 2012 Financial Results Conference Call
April 20, 2012 08:30 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., April 20, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals logo
Momenta to Present at the Barclays Capital Global Healthcare Conference
March 12, 2012 12:30 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., March 12, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals logo
Momenta to Present at the Cowen and Company 32nd Annual Health Care Conference
March 02, 2012 15:30 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., March 2, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals logo
Momenta to Present at the 2012 Citi Global Health Care Conference
February 24, 2012 16:30 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals logo
Momenta to Present at the Leerink Swann 2012 Global Healthcare Conference
February 13, 2012 17:00 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals logo
Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2011
February 09, 2012 08:30 ET | Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...